APO Research
Talk to an analyst

APO RESEARCH · REPORT

Companion Animal Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Companion Animal Vaccines Market Analysis and Forecast 2026-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchCompanion Animal Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Companion Animal Vaccines Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Companion Animal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Companion Animal Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Companion Animal Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Companion Animal Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Companion Animal Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Companion Animal Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Companion Animal Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Companion Animal Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Companion Animal Vaccines include Merck, Eli Lilly, Bayer, Vetoquinol, Merial, Heska, Ceva and Boehringer Ingelheim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Companion Animal Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Companion Animal Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Companion Animal Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Companion Animal Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Companion Animal Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Companion Animal Vaccines sales, projected growth trends, production technology, application and end-user industry.

Companion Animal Vaccines Segment by Company

Merck

Eli Lilly

Bayer

Vetoquinol

Merial

Heska

Ceva

Boehringer Ingelheim

Companion Animal Vaccines Segment by Type

Recombinant Vaccines

Subunit Vaccines

Inactivated Vaccines

Toxoid Vaccines

Conjugate Vaccines

Attenuated Live Vaccines

DNA Vaccines

Companion Animal Vaccines Segment by Application

Canine

Avian

Feline

Companion Animal Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Companion Animal Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Companion Animal Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Companion Animal Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Companion Animal Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Recombinant Vaccines Major Manufacturers Table 3. Subunit Vaccines Major Manufacturers Table 4. Inactivated Vaccines Major Manufacturers Table 5. Toxoid Vaccines Major Manufacturers Table 6. Conjugate Vaccines Major Manufacturers Table 7. Attenuated Live Vaccines Major Manufacturers Table 8. DNA Vaccines Major Manufacturers Table 9. Global Companion Animal Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Canine Major Manufacturers Table 11. Avian Major Manufacturers Table 12. Feline Major Manufacturers Table 13. Companion Animal Vaccines Industry Trends Table 14. Companion Animal Vaccines Industry Drivers Table 15. Companion Animal Vaccines Industry Opportunities and Challenges Table 16. Companion Animal Vaccines Industry Restraints Table 17. Global Companion Animal Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Companion Animal Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Companion Animal Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Companion Animal Vaccines Revenue Market Share by Region (2021-2026) Table 21. Global Companion Animal Vaccines Revenue Market Share by Region (2027-2032) Table 22. Global Companion Animal Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 23. Global Companion Animal Vaccines Sales by Region (2021-2026) & (W Units) Table 24. Global Companion Animal Vaccines Sales by Region (2027-2032) & (W Units) Table 25. Global Companion Animal Vaccines Sales Market Share by Region (2021-2026) Table 26. Global Companion Animal Vaccines Sales Market Share by Region (2027-2032) Table 27. Global Companion Animal Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Companion Animal Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Companion Animal Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Companion Animal Vaccines Sales Market Share by Manufacturers (2021-2026) Table 31. Global Companion Animal Vaccines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Companion Animal Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Companion Animal Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Companion Animal Vaccines Manufacturers, Product Type & Application Table 35. Global Companion Animal Vaccines Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Companion Animal Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Companion Animal Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Companion Animal Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Companion Animal Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Companion Animal Vaccines Revenue Market Share by Type (2021-2026) Table 42. Global Companion Animal Vaccines Revenue Market Share by Type (2027-2032) Table 43. Global Companion Animal Vaccines Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 44. Global Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 45. Global Companion Animal Vaccines Sales by Type (2027-2032) & (W Units) Table 46. Global Companion Animal Vaccines Sales Market Share by Type (2021-2026) Table 47. Global Companion Animal Vaccines Sales Market Share by Type (2027-2032) Table 48. Global Companion Animal Vaccines Price by Type (2021-2026) & (US$/Unit) Table 49. Global Companion Animal Vaccines Price by Type (2027-2032) & (US$/Unit) Table 50. Global Companion Animal Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Companion Animal Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Companion Animal Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Companion Animal Vaccines Revenue Market Share by Application (2021-2026) Table 54. Global Companion Animal Vaccines Revenue Market Share by Application (2027-2032) Table 55. Global Companion Animal Vaccines Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 56. Global Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 57. Global Companion Animal Vaccines Sales by Application (2027-2032) & (W Units) Table 58. Global Companion Animal Vaccines Sales Market Share by Application (2021-2026) Table 59. Global Companion Animal Vaccines Sales Market Share by Application (2027-2032) Table 60. Global Companion Animal Vaccines Price by Application (2021-2026) & (US$/Unit) Table 61. Global Companion Animal Vaccines Price by Application (2027-2032) & (US$/Unit) Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Merck Companion Animal Vaccines Product Portfolio Table 66. Merck Recent Development Table 67. Eli Lilly Company Information Table 68. Eli Lilly Business Overview Table 69. Eli Lilly Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Eli Lilly Companion Animal Vaccines Product Portfolio Table 71. Eli Lilly Recent Development Table 72. Bayer Company Information Table 73. Bayer Business Overview Table 74. Bayer Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bayer Companion Animal Vaccines Product Portfolio Table 76. Bayer Recent Development Table 77. Vetoquinol Company Information Table 78. Vetoquinol Business Overview Table 79. Vetoquinol Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Vetoquinol Companion Animal Vaccines Product Portfolio Table 81. Vetoquinol Recent Development Table 82. Merial Company Information Table 83. Merial Business Overview Table 84. Merial Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Merial Companion Animal Vaccines Product Portfolio Table 86. Merial Recent Development Table 87. Heska Company Information Table 88. Heska Business Overview Table 89. Heska Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Heska Companion Animal Vaccines Product Portfolio Table 91. Heska Recent Development Table 92. Ceva Company Information Table 93. Ceva Business Overview Table 94. Ceva Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Ceva Companion Animal Vaccines Product Portfolio Table 96. Ceva Recent Development Table 97. Boehringer Ingelheim Company Information Table 98. Boehringer Ingelheim Business Overview Table 99. Boehringer Ingelheim Companion Animal Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Boehringer Ingelheim Companion Animal Vaccines Product Portfolio Table 101. Boehringer Ingelheim Recent Development Table 102. North America Companion Animal Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Companion Animal Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 105. North America Companion Animal Vaccines Sales by Type (2027-2032) & (W Units) Table 106. North America Companion Animal Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 107. North America Companion Animal Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 108. North America Companion Animal Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Companion Animal Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 111. North America Companion Animal Vaccines Sales by Application (2027-2032) & (W Units) Table 112. North America Companion Animal Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 113. North America Companion Animal Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 114. North America Companion Animal Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Companion Animal Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Companion Animal Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Companion Animal Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 118. North America Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 119. North America Companion Animal Vaccines Sales by Country (2027-2032) & (W Units) Table 120. North America Companion Animal Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 121. North America Companion Animal Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 122. United States Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 123. Canada Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 124. Europe Companion Animal Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Companion Animal Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 127. Europe Companion Animal Vaccines Sales by Type (2027-2032) & (W Units) Table 128. Europe Companion Animal Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 129. Europe Companion Animal Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 130. Europe Companion Animal Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Companion Animal Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 133. Europe Companion Animal Vaccines Sales by Application (2027-2032) & (W Units) Table 134. Europe Companion Animal Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 135. Europe Companion Animal Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 136. Europe Companion Animal Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Companion Animal Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Companion Animal Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Companion Animal Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 140. Europe Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 141. Europe Companion Animal Vaccines Sales by Country (2027-2032) & (W Units) Table 142. Europe Companion Animal Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 143. Europe Companion Animal Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 144. Germany Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 145. France Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 146. U.K. Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 147. Italy Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 148. Netherlands Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 149. Nordic Countries Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 150. China Companion Animal Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 151. China Companion Animal Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 152. China Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 153. China Companion Animal Vaccines Sales by Type (2027-2032) & (W Units) Table 154. China Companion Animal Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 155. China Companion Animal Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 156. China Companion Animal Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 157. China Companion Animal Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 158. China Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 159. China Companion Animal Vaccines Sales by Application (2027-2032) & (W Units) Table 160. China Companion Animal Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 161. China Companion Animal Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 162. Asia Companion Animal Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia Companion Animal Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 165. Asia Companion Animal Vaccines Sales by Type (2027-2032) & (W Units) Table 166. Asia Companion Animal Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 167. Asia Companion Animal Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 168. Asia Companion Animal Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia Companion Animal Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 171. Asia Companion Animal Vaccines Sales by Application (2027-2032) & (W Units) Table 172. Asia Companion Animal Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 173. Asia Companion Animal Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 174. Asia Companion Animal Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Companion Animal Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Asia Companion Animal Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Asia Companion Animal Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 178. Asia Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 179. Asia Companion Animal Vaccines Sales by Country (2027-2032) & (W Units) Table 180. Asia Companion Animal Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 181. Asia Companion Animal Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 182. Japan Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 183. South Korea Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 184. India Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 185. Australia Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 186. China Taiwan Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 187. Southeast Asia Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 188. SAMEA Companion Animal Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA Companion Animal Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 191. SAMEA Companion Animal Vaccines Sales by Type (2027-2032) & (W Units) Table 192. SAMEA Companion Animal Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 193. SAMEA Companion Animal Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 194. SAMEA Companion Animal Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 195. SAMEA Companion Animal Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 196. SAMEA Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 197. SAMEA Companion Animal Vaccines Sales by Application (2027-2032) & (W Units) Table 198. SAMEA Companion Animal Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 199. SAMEA Companion Animal Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 200. SAMEA Companion Animal Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. SAMEA Companion Animal Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. SAMEA Companion Animal Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. SAMEA Companion Animal Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 204. SAMEA Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 205. SAMEA Companion Animal Vaccines Sales by Country (2027-2032) & (W Units) Table 206. SAMEA Companion Animal Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 207. SAMEA Companion Animal Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Brazil Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 209. Argentina Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 210. Chile Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 211. Colombia Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 212. Peru Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 213. Saudi Arabia Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 214. Israel Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 215. UAE Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 216. Turkey Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 217. Iran Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 218. Egypt Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. Companion Animal Vaccines Distributors List Table 222. Companion Animal Vaccines Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. Companion Animal Vaccines Image Figure 2. Global Companion Animal Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Companion Animal Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Recombinant Vaccines Image Figure 5. Subunit Vaccines Image Figure 6. Inactivated Vaccines Image Figure 7. Toxoid Vaccines Image Figure 8. Conjugate Vaccines Image Figure 9. Attenuated Live Vaccines Image Figure 10. DNA Vaccines Image Figure 11. Global Companion Animal Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Companion Animal Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 13. Canine Image Figure 14. Avian Image Figure 15. Feline Image Figure 16. Global Companion Animal Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 18. Global Companion Animal Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Companion Animal Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Companion Animal Vaccines Revenue Market Share by Region (2021-2032) Figure 21. Global Companion Animal Vaccines Sales (2021-2032) & (W Units) Figure 22. Global Companion Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 23. Global Companion Animal Vaccines Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Companion Animal Vaccines Sales YoY (2021-2032) & (W Units) Figure 25. Europe Companion Animal Vaccines Sales YoY (2021-2032) & (W Units) Figure 26. China Companion Animal Vaccines Sales YoY (2021-2032) & (W Units) Figure 27. Asia (Excluding China) Companion Animal Vaccines Sales YoY (2021-2032) & (W Units) Figure 28. South America, Middle East and Africa Companion Animal Vaccines Sales YoY (2021-2032) & (W Units) Figure 29. Global Companion Animal Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Companion Animal Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Companion Animal Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Companion Animal Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Companion Animal Vaccines Revenue Market Share by Type (2021-2032) Figure 35. Global Companion Animal Vaccines Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Companion Animal Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Companion Animal Vaccines Sales Market Share by Type (2021-2032) Figure 38. Global Companion Animal Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Companion Animal Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Companion Animal Vaccines Revenue Market Share by Application (2021-2032) Figure 41. Global Companion Animal Vaccines Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 42. Global Companion Animal Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Companion Animal Vaccines Sales Market Share by Application (2021-2032) Figure 44. North America Companion Animal Vaccines Revenue Share by Type (2021-2032) Figure 45. North America Companion Animal Vaccines Sales Share by Type (2021-2032) Figure 46. North America Companion Animal Vaccines Revenue Share by Application (2021-2032) Figure 47. North America Companion Animal Vaccines Sales Share by Application (2021-2032) Figure 48. North America Companion Animal Vaccines Revenue Share by Country (2021-2032) Figure 49. North America Companion Animal Vaccines Sales Share by Country (2021-2032) Figure 50. Europe Companion Animal Vaccines Revenue Share by Type (2021-2032) Figure 51. Europe Companion Animal Vaccines Sales Share by Type (2021-2032) Figure 52. Europe Companion Animal Vaccines Revenue Share by Application (2021-2032) Figure 53. Europe Companion Animal Vaccines Sales Share by Application (2021-2032) Figure 54. Europe Companion Animal Vaccines Revenue Share by Country (2021-2032) Figure 55. Europe Companion Animal Vaccines Sales Share by Country (2021-2032) Figure 56. China Companion Animal Vaccines Revenue Share by Type (2021-2032) Figure 57. China Companion Animal Vaccines Sales Share by Type (2021-2032) Figure 58. China Companion Animal Vaccines Revenue Share by Application (2021-2032) Figure 59. China Companion Animal Vaccines Sales Share by Application (2021-2032) Figure 60. Asia Companion Animal Vaccines Revenue Share by Type (2021-2032) Figure 61. Asia Companion Animal Vaccines Sales Share by Type (2021-2032) Figure 62. Asia Companion Animal Vaccines Revenue Share by Application (2021-2032) Figure 63. Asia Companion Animal Vaccines Sales Share by Application (2021-2032) Figure 64. Asia Companion Animal Vaccines Revenue Share by Country (2021-2032) Figure 65. Asia Companion Animal Vaccines Sales Share by Country (2021-2032) Figure 66. SAMEA Companion Animal Vaccines Revenue Share by Type (2021-2032) Figure 67. SAMEA Companion Animal Vaccines Sales Share by Type (2021-2032) Figure 68. SAMEA Companion Animal Vaccines Revenue Share by Application (2021-2032) Figure 69. SAMEA Companion Animal Vaccines Sales Share by Application (2021-2032) Figure 70. SAMEA Companion Animal Vaccines Revenue Share by Country (2021-2032) Figure 71. SAMEA Companion Animal Vaccines Sales Share by Country (2021-2032) Figure 72. Companion Animal Vaccines Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Companion Animal Vaccines Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Subunit Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • Attenuated Live Vaccines
  • DNA Vaccines
Applications
  • Canine
  • Avian
  • Feline
Companies covered
  • Merck
  • Eli Lilly
  • Bayer
  • Vetoquinol
  • Merial
  • Heska
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Companion Animal Vaccines Market by Type
  3. 1.2.1 Global Companion Animal Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Recombinant Vaccines
  5. 1.2.3 Subunit Vaccines
  6. 1.2.4 Inactivated Vaccines
  7. 1.2.5 Toxoid Vaccines
  8. 1.2.6 Conjugate Vaccines
  9. 1.2.7 Attenuated Live Vaccines
  10. 1.2.8 DNA Vaccines
  11. 1.3 Companion Animal Vaccines Market by Application
  12. 1.3.1 Global Companion Animal Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Canine
  14. 1.3.3 Avian
  15. 1.3.4 Feline
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Companion Animal Vaccines Market Dynamics
  1. 2.1 Companion Animal Vaccines Industry Trends
  2. 2.2 Companion Animal Vaccines Industry Drivers
  3. 2.3 Companion Animal Vaccines Industry Opportunities and Challenges
  4. 2.4 Companion Animal Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Companion Animal Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Companion Animal Vaccines Revenue by Region
  3. 3.2.1 Global Companion Animal Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Companion Animal Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Companion Animal Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Companion Animal Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Companion Animal Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Companion Animal Vaccines Sales by Region
  9. 3.4.1 Global Companion Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Companion Animal Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Companion Animal Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Companion Animal Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Companion Animal Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Companion Animal Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Companion Animal Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Companion Animal Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Companion Animal Vaccines Sales by Manufacturers
  6. 4.2.1 Global Companion Animal Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Companion Animal Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Companion Animal Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Companion Animal Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Companion Animal Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Companion Animal Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Companion Animal Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Companion Animal Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Companion Animal Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Companion Animal Vaccines Tier 1, Tier 2, and Tier 3
5 Companion Animal Vaccines Market by Type
  1. 5.1 Global Companion Animal Vaccines Revenue by Type
  2. 5.1.1 Global Companion Animal Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Companion Animal Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Companion Animal Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Companion Animal Vaccines Sales by Type
  6. 5.2.1 Global Companion Animal Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Companion Animal Vaccines Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Companion Animal Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Companion Animal Vaccines Price by Type
6 Companion Animal Vaccines Market by Application
  1. 6.1 Global Companion Animal Vaccines Revenue by Application
  2. 6.1.1 Global Companion Animal Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Companion Animal Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Companion Animal Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Companion Animal Vaccines Sales by Application
  6. 6.2.1 Global Companion Animal Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Companion Animal Vaccines Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Companion Animal Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Companion Animal Vaccines Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Companion Animal Vaccines Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Companion Animal Vaccines Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Companion Animal Vaccines Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 Vetoquinol
  20. 7.4.1 Vetoquinol Company Information
  21. 7.4.2 Vetoquinol Business Overview
  22. 7.4.3 Vetoquinol Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Vetoquinol Companion Animal Vaccines Product Portfolio
  24. 7.4.5 Vetoquinol Recent Developments
  25. 7.5 Merial
  26. 7.5.1 Merial Company Information
  27. 7.5.2 Merial Business Overview
  28. 7.5.3 Merial Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merial Companion Animal Vaccines Product Portfolio
  30. 7.5.5 Merial Recent Developments
  31. 7.6 Heska
  32. 7.6.1 Heska Company Information
  33. 7.6.2 Heska Business Overview
  34. 7.6.3 Heska Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Heska Companion Animal Vaccines Product Portfolio
  36. 7.6.5 Heska Recent Developments
  37. 7.7 Ceva
  38. 7.7.1 Ceva Company Information
  39. 7.7.2 Ceva Business Overview
  40. 7.7.3 Ceva Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ceva Companion Animal Vaccines Product Portfolio
  42. 7.7.5 Ceva Recent Developments
  43. 7.8 Boehringer Ingelheim
  44. 7.8.1 Boehringer Ingelheim Company Information
  45. 7.8.2 Boehringer Ingelheim Business Overview
  46. 7.8.3 Boehringer Ingelheim Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Boehringer Ingelheim Companion Animal Vaccines Product Portfolio
  48. 7.8.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Companion Animal Vaccines Market Size by Type
  2. 8.1.1 North America Companion Animal Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Companion Animal Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Companion Animal Vaccines Price by Type (2021-2032)
  5. 8.2 North America Companion Animal Vaccines Market Size by Application
  6. 8.2.1 North America Companion Animal Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Companion Animal Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Companion Animal Vaccines Price by Application (2021-2032)
  9. 8.3 North America Companion Animal Vaccines Market Size by Country
  10. 8.3.1 North America Companion Animal Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Companion Animal Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Companion Animal Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Companion Animal Vaccines Market Size by Type
  2. 9.1.1 Europe Companion Animal Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Companion Animal Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Companion Animal Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Companion Animal Vaccines Market Size by Application
  6. 9.2.1 Europe Companion Animal Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Companion Animal Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Companion Animal Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Companion Animal Vaccines Market Size by Country
  10. 9.3.1 Europe Companion Animal Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Companion Animal Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Companion Animal Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Companion Animal Vaccines Market Size by Type
  2. 10.1.1 China Companion Animal Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Companion Animal Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Companion Animal Vaccines Price by Type (2021-2032)
  5. 10.2 China Companion Animal Vaccines Market Size by Application
  6. 10.2.1 China Companion Animal Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Companion Animal Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Companion Animal Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Companion Animal Vaccines Market Size by Type
  2. 11.1.1 Asia Companion Animal Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Companion Animal Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Companion Animal Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Companion Animal Vaccines Market Size by Application
  6. 11.2.1 Asia Companion Animal Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Companion Animal Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Companion Animal Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Companion Animal Vaccines Market Size by Country
  10. 11.3.1 Asia Companion Animal Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Companion Animal Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Companion Animal Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Companion Animal Vaccines Market Size by Type
  2. 12.1.1 SAMEA Companion Animal Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Companion Animal Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Companion Animal Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Companion Animal Vaccines Market Size by Application
  6. 12.2.1 SAMEA Companion Animal Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Companion Animal Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Companion Animal Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Companion Animal Vaccines Market Size by Country
  10. 12.3.1 SAMEA Companion Animal Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Companion Animal Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Companion Animal Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Companion Animal Vaccines Value Chain Analysis
  2. 13.1.1 Companion Animal Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Companion Animal Vaccines Production Mode & Process
  6. 13.2 Companion Animal Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Companion Animal Vaccines Distributors
  9. 13.2.3 Companion Animal Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst